This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Animals assigned to this project have been successfully infected with a primate lentivirus. The purpose is to continue health, virologic and immunologic monitoring for an extended period of time. The current animals have been infected with HIV-1 over 16 years at this time, and all continue to demonstrate seropositive responses to HIV-1 proteins. This indication of continuing but controlled HIV-1 replication has led us to design an experiment to examine the role of CD8+ cells in virus control by temporarily depleting CD8+ cells in vivo by treatment with the humanized mouse monoclonal anti-CD8 antibody, cM-T807. Generally, CD8-depleted virus-controlling macaques experience a coincident marked increase in virus replication and then regain control when CD8+ cells return to pretreatment levels. This spike of virus replication may permit the characterization and possible further passage and adaptation of viral species isolated, which would aid in the development of a non-human primate model for AIDS utilizing the same virus that causes disease in humans, a long-desired goal of researchers in the field of HIV vaccine and therapeutics design.
Showing the most recent 10 out of 320 publications
